comparemela.com

Latest Breaking News On - Biotechnology holdings - Page 3 : comparemela.com

Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session - ABVC BioPharma (NASDAQ:ABVC), Align Tech (NASDAQ:ALGN)

Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control.

United-states
Mexico
Mexican
American
Ultralife-corporation
Quantumscape-corporation
Novocure-limited
Joe-company
Edwards-lifesciences-corporation
National-vision-holdings
National-vision-holdings-inc

LIXTE Biotechnology Announces Closing of $3.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market under Nasdaq Rules

LIXTE Biotechnology Announces Closing of $3.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market under Nasdaq Rules
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-states
New-york
Roger-pondel
Flaurie-berman
Nasdaq
Securities-exchange
Pondelwilkinson-inc
A-gp-alliance-global-partners
Exchange-commission
Biotechnology-holdings-inc
Biotechnology-holdings
Announces-closing

Short Interest in Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) Decreases By 28.7%

Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT – Get Free Report) saw a large decrease in short interest in June. As of June 30th, there was short interest totalling 8,700 shares, a decrease of 28.7% from the June 15th total of 12,200 shares. Based on an average trading volume of 20,700 shares, the short-interest ratio is presently […]

Nasdaq
Geode-capital-management
Ep-wealth-advisors
Lixte-biotechnology-holdings-inc
Ethos-financial-group
Lixte-biotechnology-company-profile
Renaissance-technologies
Lixte-biotechnology-holdings
Get-free-report
Biotechnology-stock-down
Lixte-biotechnology

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.